Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
William R. Nunery, MD, FACS
Healthcare Professional Professor
Department of Ophthalmology
and Visual Sciences
KY Lions Eye Center
University of Louisville
301 E. Muhammad Ali Blvd.
Louisville, Kentucky, United States
Born in Lexington, Kentucky, Dr. Nunery attended Case Western Reserve School of Medicine. He completed a general surgery internship at UC-San Diego, ophthalmology residency at Indiana University, and his oculofacial plastic & orbital surgery fellowship training at Emory University.
Dr. Nunery served as the Director of Oculofacial Plastic & Orbital Surgery at Indiana University and Methodist Hospital of Indianapolis from 1980 to 2015. Dr. Nunery has also lectured internationally in Canada, South Africa, Israel, Saudi Arabia and served as visiting professor at numerous universities, including Harvard, Yale, and UCLA. He is past President of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS).
Dr. Nunery has published numerous articles and textbook chapters on topics such as Graves’ Disease, reconstruction of the anophthalmic socket, repair of orbital and periorbital trauma, numerous orbital and lacrimal topics. He has taught an ASOPRS fellowship in oculofacial plastic and orbital surgery for the past 30 years. His areas of interest are oculofacial plastic & orbital surgery, ophthalmic Graves disease, orbitofacial trauma, eyelid deformity and malposition, orbital tumors, etc.
Representative Publications:
The Association of Cigarette Smoking With Clinical Subtypes of Ophthalmic Graves’ Disease
Ocular Surface Effects of Thyroid Disease
myBinderRelated Content
-
Relation between Therapy Options for Graves’ Disease and the Course of Graves’ Ophthalmopathy: A Systema...Background: The relation between therap...
-
Comparison of Two Different Regimens of Intravenous Methylprednisolone for Patients With Moderate to Severe and Acti...The intravenous methylprednisolone (iv M...
-
FDA Approves First Treatment for Thyroid Eye Disease (Teprotumumab)The U.S. Food and Drug Administration (F...
-
Which Factors are Associated With Quality of Life in Patients With Graves’ Orbitopathy Presenting for Orbital ...Purpose: Graves' orbitopathy (GO) is as...
-
Anatomic Considerations in Thyroid Eye DiseasePurpose: To review and summarize the cl...
-
New Data from Teprotumumab Phase 3 OPTIC Study Shows Significantly Reduced Double Vision and Improved Quality of Lif...Horizon Therapeutics plc today announced...
-
Does Early Response to Intravenous Glucocorticoids Predict the Final Outcome in Patients With Moderate-To-Severe and...Purpose: Intravenous glucocorticoids (i...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Google